Boston Scientific Corp. shares, which sank to a 3-1/2 year low earlier this week, rose by as much as 5% on Friday after a favorable court ruling in a long-standing patent battle with archrival Johnson & Johnson.
*For more on this story,
read the full Reuters article.
